A criterion was established in a previous study to detect the relapse of adult acute leukemia in its early stage, i.e., when lymphocytes in peripheral blood increased over 45% of the leukocytes during the maintenance therapy, bone marrow puncture was immediately performed to examine the leukemic cells. By this criterion the relapse was detected earlier than by other criteria. To study the effect of early detection of the relapse in adult acute leukemia on the results, the second remission rate and the survival time were compared between the following groups. Group I consisted of 11 patients, whose relapse was determined by our criterion. Group II consisted of 8 patients whose relapse was determined by the appearance of leukemic cells in peripheral blood. The second remission was accomplished in 7 of 11 patients in Group 1(64%) and in 1 of 8 in Group 11 (13%) (p <0.05). The mean (+s.D.) duration of complete remission in Group I was 9.7+ 7.8 months and not significantly longer than the value in Group 11(5.3 +3.9 months). The interval from relapse to death was 10.3±5.9 and 6.1±3.8 months in Groups I and II, respectively. The interval from relapse to death of 7 patients who accomplished the second remission in Group I was 12.5+5.5 months. This interval was significantly longer than in Group II (p <0.02). The mean survival time was 22.2± 9.6 months in Group I and 13+ 2.5 months in Group II. The mean survival time of 7 patients accomplished the second remission in Group I was 26. 7±9.4 months which was significantly longer than in Group II (p <0.01). The results showed that our criterion to detect relapse in the early stage was effective for prolongation of the survival time in adult acute leukemia. early detection of relapse ; adult acute leukemia ; percentage of lymphocyte ; survival time ; second remission rate
induction therapy and the detection of early relapse. In the previous study (Kawamura et al. 1981 ), i.e., the criterion was established to detect the relapse of adult leukemia in its early stage, when the share of lymphocytes in peripheral blood increased over 45% of the leucocytes during the maintenance therapy, bone marrow puncture was immediatly performed to examine the appearance of leukemic cells. By this criterion, the relapse was detect earlier than by other criteria.
In the present study, effects of the early detection of the relapse in adult acute leukemia on the second remission rate and survival time were evaluated.
PATIENTS AND METHODS
Patients. Of 56 acute leukemia patients admitted to our department from August 1977 to July 1980, 29 patients who had the first remission were subjected to this study. These 29 patients were divided into two groups not deliberately. Group I consisted of 11 patients (aged 16-75 years) whose relapse was determined by our criterion, 4 patients with acute myelogenous leukemia (M2), 4 with acue promyelocytic leukemia (M3), 1 with monocytic leukemia (M5) and 2 with acute lymphocytic leukemia (L2). Group II consisted of 8 patients (aged 17-63 years) whose relapse was determined by the appearance of leukemic cells in peripheral blood ; 6 with acute myelogenous leukemia (M2), 1 with acute promyelocytic leukemic (M3), 1 with acute lymphocytic leukemia (L2) ( Table 1 ). The complete remission was defined according to Kimura's criteria (Kimura et al. 1957) . Relapse was indicated when leukemic cells were over 5% of the nucleated cells in the bone marrow aspirate.
Methods. Our previous study (kawamura et al. 1981) suggested that lymphocytes exceeding 40-45% of leukocytes in peripheral blood may foreshow the relapse. Therefore in the present study, when the percentage of lymphocytes exceeded this level, bone marrow puncture was immediately performed to examine the relapse in Group I. The relapse of patients in Group II was determined by the appearance of leukemic cells in peripheral blood smear. There was no difference in induction therapy or reinduction therapy between Groups I and II ( Table 2) . The results were expressed in terms of mean+s.D. when necessary.
RESULTS

Hematological examination at relapse
There were significant differences between Groups I and II in the data such as WBC and percentages of leukemic cells and lymphocytes in peripheral blood (Table 3) .
Second remission rate A second remission rate of 64% in Group I was significantly higher than that (13%) in Group II (p <0.01) (Fig. 1) .
The mean survival time
The mean survival time of 22.2 + 9.6 months in Group I was significantly longer than that in Group II which was 13.1+2.5 months (p <0.02) ( Table 4) . The interval from relapse to death
The interval from relapse to death was 12.5 + 5.5 months in 7 patients of Group I who had the second remission and the corresponding interval in Group II was 6.1± 3.8 months ( Table 4 ).
The duration of complete remission
The mean duration of complete remission in Group I was 9.7± 7.8 months, , second remission in Group I (n = 7). (Table 4) .
DISCUSSION
Recently, the remission rate of adult acute leukemia has increased rapidly and the rates of 80% or higher have been obtained even for acute myelogenous leukemia. In order to prolong the survival time further, and it is important to investigate this disease toward two directions ; 1) establishment of ideal remission maintenance therapy and 2) early detection of relapse and early treatment. The authors have discussed the possibility to predict relapse in the bone marrow before the appearance of leukemic cells in the peripheral blood without frequent bone marrow punctures in patients who had already attained complete remission and had been on maintenance therapy.
According to our previous case study (Kawamura et al. 1981) , the relapse was confirmed by bone marrow puncture in 10 of 12 cases (83%) in which the peripheral lymphocyte value was raised over 45%. The leukemic cells in the bone marrow were 10% or less at the time of relapse in 4 of the 10 cases and those in the peripheral blood were 0% in 9 cases. In 2 cases of the 12, the relapse occurred even when the peripheral lymphocytes were less than 45% of the leukocyses ; one had complicated hepatic dysfunctions and the other was hypoplastic leukemia. Since there was no difference in either the first or the second remission induction therapy or in duration of the first remission between Groups I and II in the present study, the prolonged survival time in Group I is ascribable to the prolonged interval from relapse to death. Although it is most important to maintain the first remission for long term survival in acute leukemia, systematic maintenance therapy has not yet been established. Therefore, early detection of relapse described above is considered useful to increase the rate of the second remission and to prolong the survival time.
Recently, the activities of various enzymes such as fucosyl transferase (Khilanani et al. 1977) , sialyltranferase (Lin et al. 1981) , adenosine deaminase (Sako et al. 1981 ) and arylsulf atase (Posey et al. 1979 ) were investigated to examine proliferation of leukemic cells. It has never been demonstrated clinically, however, that the activities of these enzymes can serve as the criteria for early detection of relapse. Baker et al. (1979) reported that serial monitoring of patients in remission with use of heteroantiserum to leukemia-associated antigens appeared to allow detection of imminent relapse 3.7 months on average before morphologically detectable relapse occurs in the bone marrow. Kawai et al.
(1983) carried out cytostatic assay in child leukemia using patient's mononuclear cells as effector cells and Molt-3 cell line derived from human leukemic cells as target cells and noted that cytostatic activity was depressed 4-8 weeks before the relapse. So far as the authors reviewed the literature, our criterion would be one of the easiest and best way to detect the relapse of leukemia early. The present study
